NEWS
Find a Professional: Explore Experts Across 197 Disciplines in 221 Countries!
Just Updated: Compare Your Institution (Live Data)
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025 (Updated Today)
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
Login
Register & Pricing
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
For Students
local_fire_department
Country Reports
person
Find a Professional
James Campbell
Institute of Cancer Research University of London - London / United Kingdom
Natural Sciences / Molecular Biology & Genetics
AD Scientific Index ID: 1600771
Registration, Add Profile,
Premium Membership
Get Your Global Impact Certificate
Institute of Cancer Research University of London
Ranking &
Analysis
Job
Experiences
Education
Information
Published Books
Book Chapters
Articles
Presentations
Lessons
Projects
Co-Authors
Subject Leaders
Editorship, Referee &
Scientific Board
Patents /
Designs
Academic Grants
& Awards
Artistic
Activities
Certificate / Course
/ Trainings
Association &
Society Memberships
Contact, Office
& Social Media
person_outline
James Campbell's MOST POPULAR ARTICLES
1-)
Proteome-based plasma biomarkers for Alzheimer's disease Brain 129 (11), 3042-3050, 2006
2-)
Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease Archives of general psychiatry 67 (7), 739-748, 2010
3-)
Genome-wide and high-density CRISPR-Cas9 screens identify point mutations in PARP1 causing PARP inhibitor resistance Nature communications 9 (1), 1849, 2018
4-)
Secondary mutations in BRCA2 associated with clinical resistance to a PARP inhibitor The Journal of pathology 229 (3), 422-429, 2013
5-)
Genome-wide profiling of genetic synthetic lethality identifies CDK12 as a novel determinant of PARP1/2 inhibitor sensitivity Cancer research 74 (1), 287-297, 2014
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept